Nesta entrevista, o professor Ziemssen apresenta o tópico de gêmeos digitais na esclerose múltipla
Gêmeos digitais na esclerose múltipla
Tjalf Ziemssen received grants from Novartis, Biogen, Roche and Sanofi. Tjalf Ziemssen reports consulting fees from Biogen, BMS, Viatris, Teva, Merck, Sanofi, Roche and Novartis, and honoraria from BMS, Viatris, Teva, Merck, Sanofi, Roche and Novartis and stocks in Bayer and Roche.